Robert W. Duggan - Dec 12, 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
Dec 12, 2023
Transactions value $
$164,691
Form type
4
Date filed
12/14/2023, 07:37 PM
Previous filing
Dec 13, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Purchase $165K +18K +0.05% $9.15 37M Dec 12, 2023 Direct F1
holding PLSE Common Stock 492K Dec 12, 2023 See footnote F3
holding PLSE Common Stock 352K Dec 12, 2023 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Volume-weighted average price.
F2 Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder.
F3 Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.